MiMedx Group is back in focus after analysts trimmed their fair value estimate from US$10.40 to US$9.60, a modest reset that still reflects a structured view of the story rather than a wholesale ...
Fintel on MSN
Citizens Initiates Coverage of MiMedx Group (MDXG) with Market Outperform Recommendation
Fintel reports that on February 23, 2026, Citizens initiated coverage of MiMedx Group (NasdaqCM:MDXG) with a Market Outperform recommendation. Analyst Price Forecast Suggests 105.18% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results